Discovery of new therapeutics for huntingtons disease through successive reversal of phenotypic signatures
Ended Project Grant Awarded Last action
- Award ID
- R43NS112090
- Recipient
-
Rumi Scientific, Inc. UEI Y1U1A5Y75CN7
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $449,904
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Funding
-
- $299,936.00 Federal
- $149,968.00 Non-federal
- Place of performance
- New York, NY 10022, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $149,968 | $0 | |
| Amendment | $149,968 | $149,968 | |
| Amendment | -$149,968 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $149,968 | $0 |
Quick answers
Who received award R43NS112090?
R43NS112090 was awarded to Rumi Scientific, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 30, 2019.
How much is award R43NS112090 worth?
$449,904 has been obligated on R43NS112090: $299,936 in federal funding and $149,968 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award